Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy

Min, Sang-Won, Cho, Seo-Hyun, Zhou, Yungui, Schroeder, Sebastian, Haroutunian, Vahram, Seeley, William W., Huang, Eric J., Shen, Yong +6 more·2010·Neuron
DOI 10.1016/j.neuron.2010.08.044

Cited by (959)

Items 801–900 of 959

  1. Modulations of SIRTUINs and Management of Brain Disorders
    Sudhir Kumar Shekhar, Sarfraj Ahmad Siddiqui, Girish Rai · 2023 · BENTHAM SCIENCE PUBLISHERS eBooks
  2. Cogs in the autophagic machine—equipped to combat dementia-prone neurodegenerative diseases
    Sholto de Wet, Rensu P. Theart, Ben Loos · 2023 · Frontiers in Molecular Neuroscience
  3. Quantification of Methylation and Phosphorylation Stoichiometry
    Christopher A. Ayoub, Khadijah I. Moore, Jeff Kuret · 2024 · Methods in molecular biology
  4. Nanotheranostic Approach for Targeting Tauopathies in Alzheimer's Disease: Mechanistic Insight and Recent Advances
    Kantrol Kumar Sahu, Ruchi Chaudhary, Mohd. Asad Farooqi, Monika Kaurav · 2024 · Drug Delivery Letters
  5. Nanoconjugate Improves Cognitive Deficit and Limits the Pathogenic Tau Burden in Okadaic‐Acid‐Induced Alzheimer's Mice
    Qiuju Liang, Shoubo Xiang, Pengzhen Wang, Lian Chen, Hongyi Cao, Tian Cheng, Tingting Jiang, Hua Zuo, Zhen Tian, Sanjib Bhattacharyya · 2025 · Advanced Therapeutics
  6. PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron
    Haotian Liu, Xinnan Liu, Fengyuan Tian, Yashuang Chen, Jingying Li, Xue Bing Wang, Wenying Qiu, Xia Wang, Chao Ma, Wei Ge · 2025 · Advanced Science
  7. Impact of Lysine Acetylation Mutations on the Structure of Full-Length Tau Fibrils
    Aurelio James Dregni, Mei Hong · 2025 · ACS Chemical Neuroscience
  8. Sirtuin1: A Potential Key Regulator in Alzheimer's Disease Pathophysiology and Therapeutics
    Preeti Chandola, Smita Jain, Pragya Sharma, Mohammad Chand Jamali, Jaya Dwivedi, Swapnil K. Sharma · 2025 · Current Enzyme Inhibition
  9. Correlation of β2-microglobulin with postoperative delirium and 3-year mortality undergoing knee or hip replacement surgery: a prospective cohort study
    Yuanlong Wang, Qian He, Kun Fu, Yanlin Bi, Bin Wang, Wenjie Kong, Shuhui Hua, Jian Kong, Shanling Xu, Hongyan Gong et al. · 2025 · Frontiers in Medicine
  10. Unraveling tau’s fold: Structural dynamics in Alzheimer’s pathogenesis
    Sarita Montaño, Nabil Itzi Luna‐Viramontes, Elvis Cuevas, Pedro Pablo Martínez-Cuevas, Mar Pacheco‐Herrero, Liliana León-López, Andrés Duran Armenta, José Luna‐Muñoz · 2025 · Advances in protein chemistry and structural biology
  11. On the potential roles of TDP-43 in the formation of membraneless organelles and their transformation into toxic aggregates
    Olga S. Sergeeva, Margarita V. Neklesova, Vladislav A. Reushev, Alexey V. Artemov, Туроверов Константин Константинович, Туроверов Константин Константинович, Vladimir Nikolaevich Uversky, Alexander V. Fonin · 2025 · Biochemical and Biophysical Research Communications
  12. Understanding the impact of cytoskeleton disruption on synaptic plasticity in Alzheimer’s disease
    Basavaraju KC, Poornima Priyadarshini · 2025 · Advances in protein chemistry and structural biology
  13. Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure
    James P Garrahy · 2025 · Journal of Alzheimer s Disease
  14. Effect of site-specific lysine acetylation on tau binding to microtubules: mechanistic insights from all-atom molecular dynamics simulations
    Pengxuan Xia, Dushuo Feng, Bote Qi, Lulu Guan, Yunxiang Sun, Yu Zou · 2026 · Physical Chemistry Chemical Physics
  15. Shugoshin 2A stabilizes heterochromatin complexes to suppress the 2-cell-like state in embryonic stem cells
    Panpan Shi, Kairang Jin, Guoxing Yin, Lin Liu · 2026 · Stem Cell Reports
  16. Ubiquitin signatures on aggregating proteins in neurodegeneration
    Subhashree Sahoo, Amrita Arpita Padhy, Kummari Shivani, Ashish Misra, Parul Mishra · 2025 · Essays in Biochemistry
  17. Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease
    Joshua T. Skrehot, Dmitry Kurouski · 2026 · Protein Science
  18. Ethanol exposure and high-fat diet: assessing the neuroimmune and metabolic mechanisms in Alzheimer’s disease pathology
    George Chigozie Njoku, Viswanathan Saraswathi · 2026 · Frontiers in Neuroscience
  19. Treatment of Alzheimer Disease with Phytochemicals Other Than Curcumin
    A. A. Farooqui · 2016 · Springer eBooks
  20. Pharmacologictherapy for FTD and related disorders
    Richard M. Tsai, Adam L. Boxer · 2015 · Cambridge University Press eBooks
  21. Molecular Pathways Leading to the Clinical Phenomenology of Frontotemporal Dementia
    Jennifer S. Yokoyama, Suzee E. Lee · 2016 · Elsevier eBooks
  22. Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
    Gabriel S. Stephens, Jason C. You, Chia-Hsuan Fu, Jeannie Chin · 2017 · Elsevier eBooks
  23. Epigenetics of Brain Aging
    Ramón Cacabelos, Óscar Teijido · 2018 · Elsevier eBooks
  24. 阿尔茨海默症治疗的药物突破
    Qiang Liu · 2024 · Chinese Science Bulletin (Chinese Version)
  25. Can Microbes Play a Role in the Pathogenesis of Alzheimer Disease?
    I. W. Fong · 2014 · Springer eBooks
  26. Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use
    Н. В. Трофимова, Irina Sergeyevna Preobrazhenskaya · 2015 · Neurology neuropsychiatry Psychosomatics
  27. Histone Deacetylases as Therapeutic Targets in Neurodegenerative Diseases
    Farahnaz Sananbenesi, André Fischer · 2016 · Elsevier eBooks
  28. Tau, Tangles and Tauopathies: Insights from Drosophila Disease Models
    Nisha Nisha, Pragati, Shweta Tandon, Aqsa Aqsa, Prerna Aggarwal, Surajit Sarkar · 2019 · Springer eBooks
  29. Update on Therapeutic Strategies for Atypical Parkinsonian Syndromes
    Mehdi Maghbooli, Vida Mohammadzadeh, Mehran Yousefi · 2020 · Turkish Journal Of Neurology
  30. The role of resveratrol treatment and regular physical activity on sirtuins in brain of rats artificially selected for intrinsic aerobic running capacity
    Linda Szűcs · 2015 · REAL-PhD (Hungarian Academy of Sciences)
  31. Epigenetics in Brain Development and Disease
    Elisabeth J. Radford, Anne C. Ferguson‐Smith, Sacri R. Ferrón · 2017 · Wiley eBooks
  32. TSC1 loss-of-function increases risk for tauopathy by inducing tau acetylation and preventing autophagy-mediated tau clearance
    Carolina Alquézar, Kathleen M. Schoch, Ethan G. Geier, Eliana Marisa Ramos, Aurora Scrivo, Kathy K Li, Andrea R. Argouarch, Elisabeth E. Mlynarski, Beth A. Dombroski, Jennifer S. Yokoyama et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Immunotherapy Against Acetylated Tau at K280 Ameliorates Behavioral Impairments and Pathologies of Tau Transgenic Mouse
    Na-Young Kim, Ha‐Lim Song, Kwangmin Cho, Young-Lim Shim, Kyounghye Lee, Yeon‐Seon Mun, Seung‐Eun Lee, Min-Seok Kim, Hyun-Ju Kim, Dong‐Hou Kim et al. · 2020
  34. Activation of TREK-1 Potassium Channel Improved Cognitive Deficits in Alzheimer's Disease Model Mice by Modulation of Glutamate Metabolic Pathway
    Fang Li, Shu ning Zhou, Xin Zeng, Rui Yang, Xue Xi Wang, Bin Meng, Wei-lin Pei, Li Lu · 2021 · Research Square
  35. Steric-free bioorthogonal profiling of cellular acetylation and glycosylation via a fluorine-selenol displacement reaction (FSeDR)
    Yue Zhao, Mi Zhao, Zhigang Lyu, Nicole Gorman, Todd R. Lewis, Aaron R. Goldman, Hsin‐Yao Tang, Rongsheng E. Wang · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Systematic profiling of the acetyl lysine machinery reveals a role for MAPKAPK2 in bromodomain inhibitor resistance
    Pata-Eting Kougnassoukou Tchara, Jérémy Loehr, Lucas Germain, Zachary Steinhart, Beatriz Gonzalez-Badillo, Anahita Lashgari, François J.-M. Chartier, Monika Tucholska, S. Picaud, James D.R. Knight et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
  38. The Microtubule-Dissociating Tau in Neurological Disorders
    Francisco Jos, Susanna Schraen‐Maschke, Luc Buée · 2012 · InTech eBooks
  39. Pharmacodynamic Mechanisms of Tolfenamic Acid Induced SP1 Degradation Relative to Alzheimer's Disease Pathology
    Lina I. Adwan · 2013
  40. Ageing in the mammalian brain
    Sohair M. Khojah · 2015 · Enlighten: Theses (The University of Glasgow)
  41. Gladstone's AD venture
    Lev Z. Osherovich · 2011 · Science-Business eXchange
  42. Past, Present, and Future: The Behavioral Sciences.
    John G. Darley · 1971 · Contemporary Psychology
  43. NEURODEGENERATIVE DISEASES AND TAU: PATHOLOGICAL EVENTS AND MOLECULAR TARGETS
    Pierfausto Seneci · 2012 · Istituto Lombardo - Accademia di Scienze e Lettere - Rendiconti di Scienze
  44. The Role of Sirtuins in Arthritis
    Diego Kyburz, Fabienne Niederer · 2012 · Springer eBooks
  45. The Association Between Traumatic Brain Injury and Alzheimer's Disease: Mouse Models and Potential Mechanisms
    Hien Tran · 2011 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  46. DEVELOPMENT OF A LIVE-CELL ASSAY PLATFORM TO STUDY PROTEIN-PROTEIN INTERACTIONS OF MICROTUBULE-ASSOCIATED PROTEIN TAU
    Niko-Petteri Nykänen · 2012 · UEF eRepo (University of Eastern Finland)
  47. SIRT1Protectsagainst!-SynucleinAggregationby ActivatingMolecularChaperones
    Gizem Dönmez · 2012
  48. The regulation of phosphorylation of tau protein in Alzheimer's disease
    Di Tang, Han‐Chang Huang, Zhao-Feng Jiang · 2013 · Shengming de Huaxue
  49. Treatment
    Bradford Clark Dickerson · 2015 · Cambridge University Press eBooks
  50. New Small Molecule Drug Discovery for Alzheimer's Disease
    Kangning Liu, Minhua Zhang, Guhan Nagappan · 2012 · Frontiers in neuroscience
  51. Некоторые аспекты лечения когнитивных нарушений: цитиколин - фармакологические характеристики, возможные преимущества, аспекты применения
    Н. В. Трофимова, Irina Sergeyevna Preobrazhenskaya, A. Ya · 2015
  52. Inhibition of Alzheimer’s type toxic aggregates of tau with fungal secondary metabolites
    Smita R. Paranjape · 2015 · KU ScholarWorks (University of Kansas)
  53. Molecular and Genetic Medicine
    Gizem Dönmez · 2013
  54. Def-eating senescence?
    Giuseppe Maulucci, Giovambattista Pani · 2012
  55. Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies
    Michel Goedert · 2017 · Neurodegeneration
  56. THE ROLE OF HSF1 PROTEIN REGULATION ON NEURODEGENERATION
    Eunhee Kim · 2017
  57. SHORT COMMUNICATION Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
    David John Irwin, Todd J. Cohen, Murray Grossman, Steven Edward Arnold, Vivianna M. Van Deerlin, Y. Lee, John Q. Trojanowski · 2013
  58. Review Article Tau: From research to clinical development
    David M. Holtzman, María C. Carrillo, James A. Hendrix, Lisa J. Bain, Ana María Catafau, Laura M. Gault, Michel Goedert, Eckhard Mandelkow�, Eva‐Maria Mandelkow, David S. Miller et al. · 2016
  59. Epigenetic Dysregulation in the Basocortical Cholinergic Projection System During the Progression of Alzheimer's Disease
    Laura J. Mahady · 2018
  60. Patent Highlights June–July 2016
    Hermann AM Mucke · 2016 · Pharmaceutical Patent Analyst
  61. The role of tau in Alzheimer’s Disease: Effects of Lys-280 and Lys-281 acetylation on tau function and structure
    Brian H. Constance · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  62. Factors Related to Alzheimer’s Disease, Tau Pathology in Alzheimer’s Disease: Possible Treatments for Tau Pathology
    Yethindra Vityala · 2020 · Indian Journal of Forensic Medicine & Toxicology
  63. Therapeutic Epigenetics- A Boon to the Future
    D. Benet Bosco Dhas · 2016 · Annals of SBV
  64. Sirtuins in mechanistic target of rapamycin complex 1 signaling
    Jesús Burillo, Patricia Marqués, Beatriz Jiménez, Carlos González-Blanco, Manuel Benito, Carlos Guillén · 2021 · Elsevier eBooks
  65. Molekularne podłoże proteinopatii: przyczyna zespołów otępiennych i zaburzeń motorycznych
    Emilia Zgórzyńska, Klaudia Krawczyk, Patrycja Bełdzińska, Anna Walczewska · 2021 · Postępy Higieny i Medycyny Doświadczalnej
  66. Resveratrol and brain mitochondria
    Patrícia Coelho, Ana Cristina Rego · 2021 · Elsevier eBooks
  67. THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
    Ryan Cloyd · 2021 · UKnowledge (University of Kentucky)
  68. The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
    Vaishnavi Jadhav · 2021 · IUScholarWorks (Indiana University)
  69. INVESTIGATION INTO THE FUNCTIONAL ROLES OF TAU AND ALPHA-SYNUCLEIN IN NEURODEGENERATIVE DISEASE
    Meaghan Morris · 2014
  70. Posttranslational modifications of TDP-43
    Samir Rahman · 2021 · Elsevier eBooks
  71. A Method for Reverse Extraction of Object Statechart Diagram with Controllable Granularity.
    Jiachen Zhang, Tie Feng, Dali Li, Quan Yuan · 2006 · IASTED Conference on Software Engineering
  72. Busca por alcaloides presentes em Caliphuria subedentata como potenciais candidatos a fármacos para a Doença de Alzheimer
    Rauni Borges Marques · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  73. Introduction
    Shrestha Ghosh · 2019 · Springer theses
  74. Molecular insights into the Tau-actin interaction
    Yunior Cabrales Fontela · 2018
  75. Exploring the human Hsp70-Hop-Hsp90 system for Tau recognition
    Antonia Moll · 2022
  76. Cellular Mechanisms of Dementia
    Li Gan · 2017 · Oxford University Press eBooks
  77. Role of SIRT1 in Epigenetics
    Zhipeng A. Wang, Willie W. Hsu, Wenshe Ray Liu · 2017 · Springer eBooks
  78. In brief
    2010 · Nature Reviews Drug Discovery
  79. In brief
    2010 · Nature reviews. Neuroscience
  80. Histone Deacetylase 6 at Crossroads of Invection and Innate Immunity
    Olga Moreno-Gonzalo · 2018
  81. Mass spectrometry–based approaches for the identification of molecular mechanism of action of ayurvedic medicines in Parkinson disease
    Aparna Hegde, Shubham Sukerndeo Upadhyay, Thottethodi Subrahmanya Keshava Prasad, Prashant Kumar Modi · 2023 · Elsevier eBooks
  82. The Mechanistic Approach Involved in the Progression of Neurodegenerative Disorders
    Mashoque Ahmad Rather, Andleeb Khan, Saeed Alsharani, Sadaf Jahan, Arif Jamal Siddiqui, Sidharth Mehan, Athanasios T. Alexiou · 2023 · Springer eBooks
  83. Sirtuins in the pathogenetic therapy of neurodegenerative diseases
    Ekaterina M. Samoilova, Alina A. Ivanova, Petr P. Laktionov, Кальсин Владимир Анатольевич, Stanislav E. Romanov · 2024 · Journal of clinical practice
  84. Additional file 1 of Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
    Bai, Bing, David Vanderwall, Yuxin Li, Xusheng Wang, Suresh Poudel, Hong Wang, Dey, Kaushik Kumar, Ping‐Chung Chen, Ka Yang, Junmin Peng · 2021 · Figshare
  85. Protein Metabolism: Critical Factors Implicated in Neurodegenerative Diseases
    Jyoti Singh, Bappi Sarkar, Ashim Mukherjee, Mousumi Mutsuddi · 2024 · Springer eBooks
  86. Pharmacological Interventions for Maintaining Brain Health in Ageing
    Sadhana Sathaye · 2024 · Healthy ageing and longevity
  87. Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders
    Zhangzhong Yang, Peng Lei · 2024 · Scientia Sinica Vitae
  88. Molecular and Cellular Mechanisms of Primary Tauopathies
    Shiaoching Gong, Li Gan · 2025 · Oxford University Press eBooks
  89. Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies
    Yukti Mittal, Pankaj Kumar, Kajal Joshi, Khadga Raj Aran · 2025 · Inflammopharmacology
  90. Fluid Markers of Tau Pathology
    Naazneen Khan, Jeffrey L. Dage · 2025 · Springer eBooks
  91. Amyloid- and Tau-Targeted Therapies in Alzheimer’s Disease
    Alexander J. Rajic, Douglas R Galasko, Mark H. Tuszynski · 2025 · Springer eBooks
  92. Epigenetics and pharmacoepigenetics of age-related neurodegenerative disorders
    Ramón Cacabelos, Olaia A. Martínez-Iglesias, Natalia Cacabelos, Pablo Cacabelos, Vinogran Naidoo · 2025 · Elsevier eBooks
  93. Impaired MAPT/tau-secretory lysosomes are linked to cognitive vulnerability in Alzheimer patients
    Preeti Sharma, Anuma Pallavi, Ananya Chatterjee, Vidya Mangala Prasad, Nikhil R. Gandasi, Sivaprakasam R. Saroja · 2025 · Autophagy
  94. Multi-Target Mechanism of Curcumin Intervention in Alzheimer’s Disease (AD): From Aβ Clearance and Tau Regulation to Neuroinflammatory Inhibition
    明颐 何 · 2025 · Nursing Science
  95. Disease-specific tau polymorphs define unique protein interaction networks across proteinopathies
    Nicha Puangmalai, Nemil N. Bhatt, Nopparat Suthprasertporn, Ernesto G. Miranda-Morales, Nikita Shchankin, Madison Samples, Ahmet E. Balci, Jia Yi Liew, Mauro Montalbano, Yingxin Zhao et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Etude de la dynamique de tau dans le compartiment synaptique dans un contexte physiologique et pathologique exemple de la maladie d'Alzheimer
    Marie‐Lise Frandemiche · 2013 · theses.fr (ABES)
  97. Additional file 5 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  98. Additional file 6 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  99. Additional file 3 of Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury
    Parra Bravo, Celeste, Karen Krukowski, Barker, Sarah, Chao Wang, Li, Yaqiao, Fan, Li, Edwin Vázquez‐Rosa, Shin, Min-Kyoo, Man Ying Wong, McCullough, Louise D. et al. · 2024 · Figshare
  100. Additional file 3 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare